Dow gets Merck&#39;d
563279
Merck&#39;s withdrawal of its arthritis treatment sent the stock tumbling more than 25 percent and pushed the Dow into deeply negative territory at the open Thursday.
427704
WHITEHOUSE STATION, NJ - Shares of Merck &amp; Co. plunged nearly 10 percent Monday after a media report said documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx causes heart problems.
207824
Shares in Merck, the US pharmaceuticals giant, plunged by almost 27 per cent yesterday after the company withdrew Vioxx, its $2.5bn (Â£1.
438859
NEW YORK (CBS.MW) - US stocks traded mixed Thurday as Merck shares lost a quarter of their value, dragging blue chips lower, but the Nasdaq moved higher, buoyed by gains in the semiconductor sector.
162345
Merck & Co. Inc.  shares could rise to $70 by 2010 if the drugmaker continues to deliver on its promise of double-digit earnings growth, Barron's said in its October 29 edition.
115343
WHAT a pill Vioxx turned out to be for Merck. Between 50 cents and 60 cents a share were lopped off expected earnings this year after the US pharmaceutical giant gave up defending its painkiller in public
134954
TORONTO (CP) - North American stock markets appear poised for strong gains Friday in the fourth quarter&#39;s first day of trading as investors recover from drug company Merck &amp; Co.
704632
NEW YORK, Sept. 30 -- Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck said it would be forced to remove its best-selling Vioxx arthritis drug from the market. Merck's unexpected bad news left blue chips with a loss for the day, while high-tech stocks got a lift from bargain hunters.
552579
Company earned 60 cents a share, down from 83 cents a year earlier; Vioxx linked to heart attacks. NEW YORK  - Merck &amp; Co.
210616
Merck & Co. Inc., reeling from the recent withdrawal of its Vioxx arthritis drug, said Wednesday it expects 2005 earnings of &#36;2.42 to &#36;2.52 a share -- a decline from expected 2004 results.
738837
U.S. blue chip stocks rose on  Wednesday, helped by drugmaker Merck & Co. Inc. MRK.N, but  technology stocks fell as results from technology bellwether  Cisco Systems Inc. CSCO.O disappointed Wall Street.
310914
NEW YORK, December 8  - Merck &amp; Co (MRK.NYS) has guided to lower-than-expected 2005 earnings due to the withdrawal of its blockbuster arthritis drug, Vioxx, and increased generic competition for its cholesterol drug, Zocor.
155177
US blue chip stocks rose on Wednesday, helped by drugmaker Merck &amp; Co. Inc. (MRK), but technology stocks fell as results from technology bellwether Cisco Systems Inc.
288701
Shares of Merck plunged nearly 27 percent yesterday on news that the pharmaceutical giant was pulling the popular arthritis pain medication Vioxx off the market in the largest drug withdrawal in US history.
686772
Merck &amp; Co. shares fell as much as 7 percent to their lowest level in more than eight years after the Wall Street Journal said the drugmaker tried for years to stop safety concerns from hurting sales of its Vioxx painkiller.
310937
Shares surged on Wall Street on Friday night, pushing the Dow over 100 points higher, as tech stocks rallied and drug giant Merck staged a 1 per cent rebound following its 26 per cent fall on Thursday.
458143
Merck &amp; Co. Inc.(MRK), reeling from the recent withdrawal of its Vioxx arthritis drug, said Wednesday it expects 2005 earnings of $2.42 to $2.52 a share -- a decline from expected 2004 results.